Healthtech Startups

VitalPath designs and manufactures complex catheters and precision laser components for medical device OEMs, offering rapid prototyping and full-scale production in ISO-certified cleanroom facilities. The company serves customers across cardiology, neurology, and peripheral vascular markets with vertically integrated capabilities from design through finished device assembly.

1 investor

Vital Signals makes Signal Ring, a wearable smart ring that measures blood pressure continuously without a cuff or calibration, using a high-resolution sensor to track blood flow. It provides consumers with 24/7 cardiovascular health insights, guided reading modes, and context for each blood pressure reading.

1 investor

Vitalthings develops contactless, camera-free monitoring devices that continuously measure vital signs, sleep, and patient presence for use in hospitals, care institutions, and home care. Its products (Guardian H10, M10, View, and Somnofy) serve healthcare personnel and patients, with a stated focus on Norway and Germany.

1 investor

VitalWear develops wearable technology using advanced fiber materials. The company is in pre-seed stage and targets applications in health monitoring and sensing.

1 investor

VITAMATE is a personalized supplement platform that uses algorithms analyzing 50+ health markers to create custom vitamin and mineral combinations tailored to individual health needs and compatibility. The company serves consumers through direct sales and also offers workplace wellness installations for employee health and productivity.

1 investor

Vitana is a dental partnership organization that invests in and supports pediatric dentists and orthodontists, letting owner-dentists retain autonomy while providing capital, data, marketing, HR, and operational support to grow their practices. It serves growth-oriented practice owners in North America and offers premium practice valuations alongside business resources.

1 investor

Vita Porter builds a software platform for coordinating time-critical healthcare logistics in organ transplantation, replacing fragmented communication systems to help transplant teams coordinate organ transport more efficiently.

1 investor

Vitelle provides an AI-powered data platform that integrates multi-source health and performance signals to generate personalized insights for women. The platform serves health organizations and high-performance entities seeking to improve outcomes by closing gaps in female-specific physiological understanding.

1 investor

VITiaCARE builds personalized health plans that let patients share their conditions, medications, and health status, and communicate their needs to doctors, family, and caregivers. It includes an assistant called Kai and a rewards program, plus medication home delivery and partner deals for pharmacies, nutrition, caregivers, and health devices.

1 investor

Vitoria Pharmacy provides a pharmacy service focused on medication adherence and compliance for individuals in home and community-based settings, including those in ICFs and the IDD population. It offers organized medication packaging and coordination with clinical teams to support providers delivering person-centered care.

1 investor

VITREA is a rehabilitation and healthcare group operating more than 70 inpatient and outpatient facilities across Germany, Austria, and Switzerland. It provides medical, nursing, and therapeutic care across various specialties to patients in different life situations.

1 investor

Vitroprobe Analytics develops a patented biomolecular analysis method using Atom Probe Tomography to examine drug targets and their interactions at near-atomic resolution, helping pharmaceutical developers design and fine-tune new drugs. The company works in collaboration with academia and industry and originated from research at Chalmers University of Technology.

1 investor

VITRUVIAE is a biotechnology company developing cancer immunotherapies that target sugars and lipids found on tumor cells but not on healthy cells, aiming to improve tumor selectivity and counter drug resistance. Its dual sugar-lipid targeting platform is engineered into formats such as T-cell engagers, CAR immune cells, and radioactive delivery platforms, with a lead program (VTRU200) for acute myeloid leukemia.

1 investor

Vittas provides tailored financing solutions and loan management software for healthcare businesses, pharmacies, hospitals, and fintech operators. The company offers fast, flexible funding with data-driven assessments and a platform for managing loans, payments, and business finances.

1 investor

Vivacelle Bio develops phospholipid nanoparticle therapies (VBI-S and VBI-1) that restore intravascular volume and redirect excess nitric oxide to treat hypovolemia in patients with septic shock or severe blood loss. The company is running a Phase III trial for its lead asset VBI-S in septic shock patients across U.S. sites.

1 investor

Vivaldi Biosciences develops Delta NS1 vaccines designed to protect against epidemic and pandemic viral respiratory diseases. The company operates research operations in Colorado and Austria.

1 investor

Vivalyx develops organ revitalization technology aimed at improving organ vitality for transplantation. The company works in the medical biotechnology field.

1 investor

VivaMás Medical Centers operates medical facilities for elderly communities, providing comprehensive healthcare services with emphasis on personalized care. The company positions itself as a healthcare provider integrating core values of service and generosity.

1 investor

VivantX works in precision oncology, applying tumour molecular profiling and personalized therapeutics to cancer care. The company draws on advisors in medical and clinical oncology, data science, and digital health.

1 investor

AWAK Technologies develops a wearable peritoneal dialysis device that enables patients with end-stage renal disease to receive treatment at home or on the move, using regeneration technology that reduces dialysis fluid consumption by up to 90 percent. The company serves kidney disease patients seeking greater mobility and quality of life compared to traditional stationary dialysis machines.

1 investor

Vivanta offers a virtual care program that combines digital assessment, clinical measurements, and continuous monitoring to identify and reduce cardiometabolic risk among employees. It serves employers seeking to improve workforce health through medical follow-up, nutrition, and physical activity guidance delivered via an app.

1 investor

Digital health company advancing digestive care.

1 investor

Vivasure Medical develops polymer-based vascular closure devices and delivery systems for structural heart and endovascular interventions. The company operates an ISO 13485 certified manufacturing facility in Ireland and was acquired by Haemonetics Corporation in January 2026.

1 investor

Vively offers preventative healthcare in Australia through comprehensive blood testing (60-100+ biomarkers), continuous glucose monitoring, and wearable and lifestyle data, paired with practitioner support. Its app and programs help members identify health risks early and follow personalised plans built by dietitians, nurses, and other practitioners to improve metabolic, hormonal, and other health markers over time.

1 investor